Despite the possible benefits of early detection and increasing therapeutic options for Alzheimer’s disease and relative dementia, there is limited use of valuable sorting and testing tools, researchers at the University of Michigan say.
Researchers at the UM School of Public Health and Michigan Medicine studied answers from nearly 1,300 national poll participants – a large, national representative research of elderly adults – to understand her experiences and opinions and opinions Test of biological blood indicators between adults aged 65-80.
According to previous research, their study found that only about 1 in 5 elderly Americans reported that they had a cognitive examination in the past year, with such rates lower between certain groups of racial and ethnic minorities (ie Spanish, Asian American). More than 6.5 million people in the United States have Alzheimer’s disease or a relative dementia, a number that is projected to double by 2060, according to the Alzheimer’s Association.
Published in Alzheimer’s & Dementia: Diagnosis, evaluation & monitoring of the disease, the study has shown that the majority of elderly Americans know the reports of early detection – previous treatment, financial planning and others.
Even with the recognition of the potential benefits and the coverage of Medicare of the beneficiaries’ cognitive tests, the derogatory use of cognitive sorting insists, the researchers say. Millions of cases of dementia have not been diagnosed and not treated, fueled by multiple obstacles to the diagnosis of the patient, provider and healthcare system, which the details of the study.
“Life with Alzheimer’s disease or other unnecessary can affect entire families and social systems. When addressing early, individuals with their loved ones and healthcare providers can work together to make important medical, financial and legal decisions for The future, “said Chelsea Cox, a doctoral student at the Ministry of Health and Head of Health at UM ‘S School of Public Health.
The sooner a discussion of cognitive health appears, most opportunities for prevention, control and treatment of symptoms are open, said Scott Roberts, a health behavior professor and a long -term researcher of Alzheimer’s disease and dementia .
Treatments are now available to help slow down the course of Alzheimer’s disease if they started early enough and there are promising clinical trials and risk reduction strategies. Thus, for many elderly adults, discussing your doctor about your cognitive health can be just as important as your doctor about your physical health. ”
Scott Roberts, UM Health Professor of Health and Property and a long -term Alzheimer’s disease and dementia researcher
Roberts is a member of the Executive Committee of the Michigan Alzheimer’s Disease Center and the Deputy Director of the National Policy for Healthy Aging, which is based at the Institute of Health Policy and Innovation. The poll group previously published a report on raising awareness and attitudes of dementia among adults aged 50 to 80 years. The new study focuses on people aged 65 to 80 years.
Source:
Magazine reports:
- COX, CG, et al. (2025). The experiences of US adults and views on cognitive examination and biological blood indicators for Alzheimer’s disease. Alzheimer S & Dmentia Diagnosis Assessment & Niseas. doi.org/10.1002/dad2.70067.
- COX, CG, et al. (2025). The decisive factors of the diagnosis of dementia in US primary care over the last decade: a review of the field. The prevention magazine of Alzheimer’s disease. doi.org/10.1016/j.tjpad.2024.100035.
